Survey of Postoperative Pain in Photorefractive Keratectomy Using Topical versus Oral Nonsteroidal Anti-Inflammatory Drugs.
ketorolac
naproxen
nonsteroidal anti-inflammatory drugs
pain
photorefractive keratectomy
refractive surgery
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
To evaluate and compare postoperative pain following photorefractive keratectomy (PRK) in patients using a preventive regimen of oral versus topical nonsteroidal anti-inflammatory drugs (NSAIDs). A prospective, randomized, longitudinal survey of postoperative PRK pain was performed on 157 subjects in a tertiary academic medical center setting. Patients were randomized to either topical ketorolac 0.4% every 12 hours or oral naproxen sodium 220 mg every 12 hours for 72 hours following PRK, beginning at the time of surgery. The primary outcome measure was the daily peak pain score from the validated numerical rating scale (NRS) for five days after surgery. The peak pain scores were significantly higher in the oral NSAID group (mean 5.82, SD 1.94) compared to the topical NSAID group (mean 4.2, SD 2.19) (p<0.0001) after PRK. When comparing each postoperative day after PRK, the pain scores from 24 to 48 hours (day 2) were significantly higher in the oral NSAID group (mean 5.17, SD 2.25) as compared to the topical NSAID group (mean 3.21, SD 2.09) (p<0.0001). Pain scores 24-72 hours after surgery (days 2 and 3) were higher than pain scores on days 1, 4, and 5 for both groups. Twice daily oral naproxen sodium 220 mg is inferior to twice daily topical ketorolac 0.4% in the treatment of early postoperative pain after PRK. This study also identified a consistent trend in which pain scores were highest 24-72 hours after the procedure. This additional observation may be useful in understanding, preventing, and treating post-PRK pain.
Identifiants
pubmed: 32546954
doi: 10.2147/OPTH.S255441
pii: 255441
pmc: PMC7266408
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1459-1466Informations de copyright
© 2020 Ripa et al.
Déclaration de conflit d'intérêts
No author has a financial or proprietary interest in any material or method mentioned.
Références
Curr Opin Ophthalmol. 2018 Jul;29(4):306-312
pubmed: 29708926
Clin Ophthalmol. 2013;7:93-8
pubmed: 23345963
Ophthalmology. 2003 Aug;110(8):1626-31
pubmed: 12917183
J Refract Surg. 1999 Nov-Dec;15(6):661-7
pubmed: 10590004
Surv Ophthalmol. 2013 Nov-Dec;58(6):529-35
pubmed: 24160728
Int J Prev Med. 2012 Mar;3(Suppl 1):S199-206
pubmed: 22826766
Clin Ophthalmol. 2017 Apr 07;11:647-655
pubmed: 28435216
Exp Eye Res. 2003 May;76(5):521-42
pubmed: 12697417
Trans Am Ophthalmol Soc. 2001;99:205-10; discussion 210-2
pubmed: 11797308
J Cataract Refract Surg. 1999 Oct;25(10):1349-55
pubmed: 10511934
J Ophthalmol. 2019 Feb 18;2019:7029858
pubmed: 31275633
J Refract Surg. 1996 Mar-Apr;12(3):365-9
pubmed: 8705712
Am J Med. 2017 Dec;130(12):1415-1422.e4
pubmed: 28756267
Arch Ophthalmol. 2000 Aug;118(8):1129-32
pubmed: 10922213
Nepal J Ophthalmol. 2013 Jul-Dec;5(2):154-60
pubmed: 24172548
J Cataract Refract Surg. 2014 Oct;40(10):1689-96
pubmed: 24968759
Pain. 2011 Oct;152(10):2399-404
pubmed: 21856077
Saudi J Ophthalmol. 2019 Jan-Mar;33(1):88-93
pubmed: 30930670
J Cataract Refract Surg. 2004 Aug;30(8):1653-60
pubmed: 15313287
J Refract Surg. 2018 Mar 1;34(3):171-176
pubmed: 29522226
Invest Ophthalmol Vis Sci. 1997 Sep;38(10):1944-53
pubmed: 9331258
Ophthalmic Surg Lasers. 1996 May;27(5 Suppl):S477-80
pubmed: 8724155
J Cataract Refract Surg. 2019 Aug;45(8):1183-1190
pubmed: 31213328
Lancet. 2013 Aug 31;382(9894):769-79
pubmed: 23726390
Surv Ophthalmol. 2010 Mar-Apr;55(2):108-33
pubmed: 20159228
Int Ophthalmol. 2014 Feb;34(1):19-26
pubmed: 23605593
J Cataract Refract Surg. 2019 Jul;45(7):972-976
pubmed: 31029475
J Cataract Refract Surg. 2013 Jan;39(1):66-73
pubmed: 23102727
J Refract Surg. 1996 Mar-Apr;12(3):358-64
pubmed: 8705711